According to Arbutus Biopharma
's latest financial reports the company has $0.10 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.10 B | -22.53% |
2022-12-31 | $0.13 B | -19.23% |
2021-12-31 | $0.16 B | 66.17% |
2020-12-31 | $0.10 B | 40.17% |
2019-12-31 | $72.74 M | -63.67% |
2018-12-31 | $0.20 B | 9.73% |
2017-12-31 | $0.18 B | -10.11% |
2016-12-31 | $0.20 B | -62.93% |
2015-12-31 | $0.54 B | 522.12% |
2014-12-31 | $88.03 M | 48.72% |
2013-12-31 | $59.19 M | 44.66% |
2012-12-31 | $40.91 M | 686% |
2011-12-31 | $5.2 M | -51.49% |
2010-12-31 | $10.73 M | -49.98% |
2009-12-31 | $21.45 M | -43.97% |
2008-12-31 | $38.28 M | 108.43% |
2007-12-31 | $18.37 M | 11711.58% |
2006-12-31 | $0.15 M | -100.84% |
2005-12-31 | $-18.5 M | 76.18% |
2004-12-31 | $-10.5 M | -169.74% |
2003-12-31 | $15.05 M | -21.54% |
2002-12-31 | $19.18 M | -68.8% |
2001-12-31 | $61.48 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.88 M | -102.71% | Bahamas |
NRC Health
NRC | $48.95 M | -53.82% | ๐บ๐ธ USA |